nach oben

vorheriger Artikel Allergenspezifische Immuntherapie (AIT) in Öste...

Tipp

Das Handekzem

Zeitschrift:: hautnah > Ausgabe 4/2020

Autoren:: Dr. A. Gorris, Ass. Prof. OA Dr. T. Kinaciyan

» Zum Volltext PDF-Version jetzt herunterladen

Wichtige Hinweise

Hinweis des Verlags

Der Verlag bleibt in Hinblick auf geografische Zuordnungen und Gebietsbezeichnungen in veröffentlichten Karten und Institutsadressen neutral.

Zusammenfassung

Obwohl das chronische Handekzem ein weit verbreitetes Problem ist und das Management sowohl für Hautärzte als auch die Betroffenen eine Herausforderung darstellt, sind die therapeutischen Möglichkeiten immer noch begrenzt, um der steigenden Prävalenz und Belastung der Erkrankung gerecht zu werden.

Coenraads P‑J (2012) Hand eczema. n Engl J Med 367:1829–1837 PubMedCrossRef

Diepgen TL, Elsner P, Schliemann S et al (2009) Guideline on the management of hand eczema ICD-10 Code: L20. L23. L24. L25. L30. J Dtsch Dermatol Ges 7(3):S1–S16 PubMed

Agner T, Andersen KE, Brandao FM et al (2008) Hand eczema severity and quality of life: a cross-sectional, multicentre study of hand eczema patients. Contact Derm 59:43–47 CrossRef

Agner T, Elsner P (2020) Hand eczema: epidemiology, prognosis and prevention. J Eur Acad Dermatol Venereol 34(1):4–12 PubMedCrossRef

Thyssen JP, Johansen JD, Linneberg A, Menné T (2010) The epidemiology of hand eczema in the general population—prevalence and main findings. Contact Derm 62:75–87 CrossRef

Johannisson A, Pontén A, Svensson Å (2013) Prevalence, incidence and predictive factors for hand eczema in young adults—a follow-up study. BMC Dermatol 13:14 PubMedPubMedCentralCrossRef

Diepgen TL (2003) Occupational skin-disease data in Europe. Int Arch Occup Environ Health 76:331–338 PubMedCrossRef

Ibler KS, Jemec GBE, Flyvholm M‑A, Diepgen TL, Jensen A, Agner T (2012) Hand eczema: prevalence and risk factors of hand eczema in a population of 2274 healthcare workers. contact Derm 67:200–207 CrossRef

Lerbaek A, Kyvik KO, Mortensen J, Bryld LE, Menné T, Agner T (2007) Heritability of hand eczema is not explained by comorbidity with atopic dermatitis. J Invest Dermatol 127:1632–1640 PubMedCrossRef

10.

de Jongh CM, Khrenova L, Verberk MM et al (2008) Loss-of-function polymorphisms in the filaggrin gene are associated with an increased susceptibility to chronic irritant contact dermatitis: a case-control study. Br J Dermatol 159:621–627 PubMedCrossRef

11.

Bryld LE, Hindsberger C, Kyvik KO, Agner T, Menné T (2003) Risk factors influencing the development of hand eczema in a population-based twin sample. Br J Dermatol 149:1214–1220 PubMedCrossRef

12.

Divkovic M, Pease CK, Gerberick GF, Basketter DA (2005) Hapten-protein binding: from theory to practical application in the in vitro prediction of skin sensitization. Contact Derm 53:189–200 CrossRef

13.

Koppes SA, Engebretsen KA, Agner T et al (2017) Current knowledge on biomarkers for contact sensitization and allergic contact dermatitis. Contact Derm 77:1–16 CrossRef

14.

Esser PR, Martin SF (2017) Pathomechanisms of contact sensitization. Curr Allergy Asthma Rep 17:83 PubMedCrossRef

15.

Vocanson M, Hennino A, Cluzel-Tailhardat M et al (2006) CD8+ T cells are effector cells of contact dermatitis to common skin allergens in mice. J Invest Dermatol 126:815–820 PubMedCrossRef

16.

Diepgen TL, Andersen KE, Chosidow O et al (2015) Guidelines for diagnosis, prevention and treatment of hand eczema. J Dtsch Dermatol Ges 13:1–22 CrossRef

17.

Jadassohn J. Zur Kenntnis der medikamentösen Dermatosen. Verhandlungen der Deutschen Dermatologischen Gesellschaft, V Congress Vienna (1895) Braumüller, Vienna, pp 103–129.1896.

18.

Gimenez-Arnau A, Maurer M, De La Cuadra J, Maibach H (2010) Immediate contact skin reactions, an update of contact urticaria, contact urticaria syndrome and protein contact dermatitis—“a never ending story.”. Eur J Dermatol 20:552–562 PubMed

19.

Agner T, Aalto-Korte K, Andersen KE et al (2015) Classification of hand eczema. J Eur Acad Dermatol Venereol 29:2417–2422 PubMedCrossRef

20.

Vester L, Thyssen JP, Menné T, Johansen JD (2012) Consequences of occupational food-related hand dermatoses with a focus on protein contact dermatitis. Contact Derm 67:328–333 CrossRef

21.

Ruff SMD, Engebretsen KA, Zachariae C et al (2018) The association between atopic dermatitis and hand eczema: a systematic review and meta-analysis. Br J Dermatol 178:879–888 PubMedCrossRef

22.

van der Heiden J, Agner T, Rustemeyer T, Clemmensen KKB (2018) Hyperkeratotic hand eczema compared to other subgroups of hand eczema—a retrospective study with a follow-up questionnaire. contact Derm 78:216–222 CrossRef

23.

Schuttelaar MLA, Coenraads PJ, Huizinga J, De Monchy JG, Vermeulen KM (2013) Increase in vesicular hand eczema after house dust mite inhalation provocation: a double-blind, placebo-controlled, cross-over study. contact Derm 68:76–85 CrossRef

24.

Bryld LE, Agner T, Menné T (2003) Relation between vesicular eruptions on the hands and tinea pedis, atopic dermatitis and nickel allergy. Acta Derm Venereol 83:186–188 PubMedCrossRef

25.

Berthold E, Weisshaar E (2019) Therapie des Handekzems. Hautarzt 70:790–796 PubMedCrossRef

26.

Koller DY, Halmerbauer G, Böck A, Engstler G (2007) Action of a silk fabric treated with AEGIS in children with atopic dermatitis: a 3-month trial. Pediatr Allergy Immunol 18:335–338 PubMedCrossRef

27.

Schaunig C, Kopera D (2017) Silk textile with antimicrobial AEM5772/5 (Dermasilk): a pilot study with positive influence on acne vulgaris on the back. Int J Dermatol 56:589–591 PubMedCrossRef

28.

Fontanini C, Berti I, Monasta L, Longo G (2013) DermaSilk in long-term control of infantile atopic dermatitis: a double blind randomized controlled trial. G Ital Dermatol Venereol 148:293–297 PubMed

29.

Stinco G, Piccirillo F, Valent F (2008) A randomized double-blind study to investigate the clinical efficacy of adding a non-migrating antimicrobial to a special silk fabric in the treatment of atopic dermatitis. Dermatology 217:191–195 PubMedCrossRef

30.

Senti G, Steinmann LS, Fischer B et al (2006) Antimicrobial silk clothing in the treatment of atopic dermatitis proves comparable to topical corticosteroid treatment. Dermatology 213:228–233 PubMedCrossRef

31.

Kinaciyan T, Stütz L, Zbyszewski A, Weiss S, Gleiss A (2010) A new barrier glove worn eight hours a day prevents relapses in hand eczema. Contact Derm 63(1):53 CrossRef

32.

Kinaciyan T, Weiss S, Zbyszewski A, Stütz L, Gleiss A (2010) A new barrier glove is as effective as a potent topical steroid for the therapy of mild to moderate severe chronic hand eczema. Contact Derm 63(1):53 CrossRef

33.

Corazza M, Federica B, Ricci M, Sarno O, Virgili A (2011) Efficacy of new barrier socks in the treatment of foot allergic contact dermatitis. Acta Derm Venereol 91(1):68–69 PubMedCrossRef

34.

Ruzicka T, Lynde CW, Jemec GBE et al (2008) Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial. Br J Dermatol 158:808–817 PubMedCrossRef

35.

Verma KK, Manchanda Y, Pasricha JS (2000) Azathioprine as a corticosteroid sparing agent for the treatment of dermatitis caused by the weed Parthenium. Acta Derm Venereol 80:31–32 PubMedCrossRef

36.

Scerri L (1999) Azathioprine in dermatological practice. An overview with special emphasis on its use in non-bullous inflammatory dermatoses. Adv Exp Med Biol 455:343–348 PubMedCrossRef

37.

Egan CA, Rallis TM, Meadows KP, Krueger GG (1999) Low-dose oral methotrexate treatment for recalcitrant palmoplantar pompholyx. J Am Acad Dermatol 40:612–614 PubMedCrossRef

38.

Oosterhaven JAF, Voorberg AN, Romeijn GLE, de Bruin-Weller MS, Schuttelaar MLA (2019) Effect of dupilumab on hand eczema in patients with atopic dermatitis: An observational study. J Dermatol 46:680–685 PubMedPubMedCentralCrossRef

39.

Zirwas MJ (2018) Dupilumab for hand eczema. J Am Acad Dermatol 79:167–169 PubMedCrossRef

40.

Weston GK, Hooper J, Strober BE (2018) Dupilumab in the treatment of Dyshidrosis: a report of two cases. J Drugs Dermatol 17(3):355–356 PubMed

41.

Oosterhaven JAF, Romeijn GLE, Schuttelaar MLA (2018) Dupilumab treatment of very severe refractory atopic hand eczema. JAMA Dermatol 154:969–970 PubMedCrossRef

Titel: Das Handekzem
Autoren:: Dr. A. Gorris
Ass. Prof. OA Dr. T. Kinaciyan
Publikationsdatum: 02.11.2020
DOI: https://doi.org/10.1007/s12326-020-00407-5
Verlag: Springer Vienna
Zeitschrift: hautnah Dermatologie, Allergologie und Ästhetische Medizin
Ausgabe 4/2020
Print ISSN: 1866-2250
Elektronische ISSN: 2192-6484

Springer Medizin Österreich

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Das Handekzem

Hinweis des Verlags

Zusammenfassung

Springer Medizin Österreich

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Hinweis des Verlags

Zusammenfassung

Weitere Artikel der Ausgabe 4/2020

Sind alternative Antibiotika bei Patienten mit Penicillinallergie unnötig?

Upadacitinib bei atopischer Dermatitis

Zellen mit Gedächtnis

Kutane Nebenwirkungen erfordern dermatologisches Konsil

Multimodale Therapiekonzepte bei Keloiden erfolgreich

Die Therapie der schweren Akne